Pleiotropic activity of antihypertensives in atherothrombogenesis. Nebivolol: increasing possibilities and reducing restrictions

The review is devoted to the recent European recommendations' view on antihypertensive medications (AHM). The role of beta-adrenoblockers (BAB) in treating arterial hypertension (AH) patients is emphasized. Existing differences in pharmacological parameters and clinical effects are discussed fo...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awdur: M. G. Bubnova
Fformat: Erthygl
Iaith:Russian
Cyhoeddwyd: «SILICEA-POLIGRAF» LLC 2008-12-01
Cyfres:Кардиоваскулярная терапия и профилактика
Pynciau:
Mynediad Ar-lein:https://cardiovascular.elpub.ru/jour/article/view/1641
_version_ 1827064040292089856
author M. G. Bubnova
author_facet M. G. Bubnova
author_sort M. G. Bubnova
collection DOAJ
description The review is devoted to the recent European recommendations' view on antihypertensive medications (AHM). The role of beta-adrenoblockers (BAB) in treating arterial hypertension (AH) patients is emphasized. Existing differences in pharmacological parameters and clinical effects are discussed for BAB of various generations. Importance of AH patients' classification by total cardiovascular risk level is explained. The important role of additional (pleiotropic) AHM effects in atherothrombogenesis control is presented, with nebivolol as an example.
first_indexed 2024-04-10T03:39:41Z
format Article
id doaj.art-9a6b711d9ab14c51a8cde9eb11f3613d
institution Directory Open Access Journal
issn 1728-8800
2619-0125
language Russian
last_indexed 2025-03-19T22:40:49Z
publishDate 2008-12-01
publisher «SILICEA-POLIGRAF» LLC
record_format Article
series Кардиоваскулярная терапия и профилактика
spelling doaj.art-9a6b711d9ab14c51a8cde9eb11f3613d2024-10-17T12:21:27Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252008-12-0176941041359Pleiotropic activity of antihypertensives in atherothrombogenesis. Nebivolol: increasing possibilities and reducing restrictionsM. G. Bubnova0State Research Center for Preventive Medicine. MoscowThe review is devoted to the recent European recommendations' view on antihypertensive medications (AHM). The role of beta-adrenoblockers (BAB) in treating arterial hypertension (AH) patients is emphasized. Existing differences in pharmacological parameters and clinical effects are discussed for BAB of various generations. Importance of AH patients' classification by total cardiovascular risk level is explained. The important role of additional (pleiotropic) AHM effects in atherothrombogenesis control is presented, with nebivolol as an example.https://cardiovascular.elpub.ru/jour/article/view/1641arterial hypertensionbeta-adrenoblockerspleiotropic effectsatherothrombogenesisnebivolol
spellingShingle M. G. Bubnova
Pleiotropic activity of antihypertensives in atherothrombogenesis. Nebivolol: increasing possibilities and reducing restrictions
Кардиоваскулярная терапия и профилактика
arterial hypertension
beta-adrenoblockers
pleiotropic effects
atherothrombogenesis
nebivolol
title Pleiotropic activity of antihypertensives in atherothrombogenesis. Nebivolol: increasing possibilities and reducing restrictions
title_full Pleiotropic activity of antihypertensives in atherothrombogenesis. Nebivolol: increasing possibilities and reducing restrictions
title_fullStr Pleiotropic activity of antihypertensives in atherothrombogenesis. Nebivolol: increasing possibilities and reducing restrictions
title_full_unstemmed Pleiotropic activity of antihypertensives in atherothrombogenesis. Nebivolol: increasing possibilities and reducing restrictions
title_short Pleiotropic activity of antihypertensives in atherothrombogenesis. Nebivolol: increasing possibilities and reducing restrictions
title_sort pleiotropic activity of antihypertensives in atherothrombogenesis nebivolol increasing possibilities and reducing restrictions
topic arterial hypertension
beta-adrenoblockers
pleiotropic effects
atherothrombogenesis
nebivolol
url https://cardiovascular.elpub.ru/jour/article/view/1641
work_keys_str_mv AT mgbubnova pleiotropicactivityofantihypertensivesinatherothrombogenesisnebivololincreasingpossibilitiesandreducingrestrictions